Metabolic cell competition in the glioblastoma tumour microenvironment: glucose, glutamine, and lactate as determinants of immune exclusion and targets for pharmacological reprogramming - Top-Institutions - MDSpire

Metabolic cell competition in the glioblastoma tumour microenvironment: glucose, glutamine, and lactate as determinants of immune exclusion and targets for pharmacological reprogramming

  • By

  • Egiroh Omene

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Cedars-Sinai
    Cedars-Sinai

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #3

    University of New Mexico Comprehensive Cancer Center
    University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico

    Key Differentiators

    • Oncology

  • #4

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology

  • #5

    The Ohio State University
    The Ohio State University

    Columbus, Ohio

    Key Differentiators

    • Oncology

Original Source(s)

Metabolic cell competition in the glioblastoma tumour microenvironment: glucose, glutamine, and lactate as determinants of immune exclusion and targets for pharmacological reprogramming

  • by Egiroh Omene

  • July 14, 2026

Related Content

Postoperative radiotherapy for resected esophageal squamous cell carcinoma: a systematic review and meta-analysis

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report

Interpretable machine learning-driven multi-omics risk stratification and drug repurposing nominates Treg/Th17 with gluconeogenesis/lactylation integration as a prognostic and druggable biomarker for glioblastoma patients